We analyze patterns of prostate growth in men diagnosed with benign prostatic hyperplasia (BPH) and treated with placebo during 4 years, and determine which baseline parameters were the strongest predictors of growth.A total of 3,040 men were enrolled in the 4-year randomized, placebo controlled Proscar Long-Term Efficacy and Safety study. Of these men a subgroup of 10
作者：C G, Roehrborn；J, McConnell；J, Bonilla；S, Rosenblatt；P B, Hudson；G H, Malek；P F, Schellhammer；R, Bruskewitz；A M, Matsumoto；L H, Harrison；H A, Fuselier；P, Walsh；J, Roy；G, Andriole；M, Resnick；J, Waldstreicher
来源：The Journal of urology 2000 年 163卷 1期
